Sintrine Oral Granules 4.15 mg Oral granules.
PDF Leaflet Revision Date: 20 February 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Prophylaxis and chronic treatment of atopic asthma in children 2 to 5 years.
Dosage (summary)
1 sachet (4 mg) daily in the evening for children 2 to 5 years.
Onset of Action / Duration
Onset: 1 day, Duration: Not specified
Special Populations
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Not recommended during pregnancy or breastfeeding.
Key Drug Interactions
- Caution with CYP inducers (e.g., phenobarbital)
- Increased montelukast exposure with gemfibrozil
Contraindications
- Known sensitivity to montelukast
- Children under 2 years
Common side effects
- Upper respiratory infection
- Headache
- Gastrointestinal disturbances
- Rash
Counselling Points
- Take daily as prescribed
- Have rescue medication available
- Do not stop other asthma medications without consulting a physician
Serious warnings
- Not for acute asthma attacks
- Monitor for neuropsychiatric events
Important Disclaimer
The Sintrine Oral Granules 4.15 mg Oral granules. professional information leaflet below is the property of Sandoz Sa 1 and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
